Stocks · Health care · Biological Products, (No Diagnostic Substances)

Surrozen, Inc.

SRZN Clue Score17
United States Fiscal year ends December CIK 0001824893 Results filed 20 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
TCG Crossover GP II, LLC
22 Jul 2026
10% owner
Sell indirect
162,500
$21.25
$3.45M
TCG Crossover GP II, LLC
22 Jul 2026
10% owner
Sell indirect
162,500
$21.25
$3.45M
Craig C Parker
4 May 2026
Chief Executive Officer
Sell
4,524
$33.33
$150.80K
Charles O Williams
4 May 2026
Chief Operating Officer
Sell
2,036
$33.33
$67.87K
Yang Li
4 May 2026
Exec. Vice President, Research
Sell
1,584
$33.33
$52.80K
Charles O Williams
5 Jan 2026
Chief Operating Officer
Sell
1,566
$19.87
$31.11K
Yang Li
5 Jan 2026
Exec. Vice President, Research
Sell
1,118
$19.87
$22.21K

What was left out

Form 4 filings counted 42
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 3,144,060
History held since 25 Nov 2020